Perrigo released Q3 2026 results

ITEM 2.02. Results of Operations and Financial Condition

On November 4, 2026, Perrigo Company plc (the "Company") released earnings for the third quarter ended September 26, 2026. The press release related to the Company's earnings is attached as Exhibit 99.1.¹

The Company provides non-GAAP financial measures as additional information that it believes is useful to investors and analysts in evaluating the performance of the Company's ongoing operating trends², facilitating comparability between periods and, where applicable, with companies in similar industries and assessing the Company's prospects for future performance. These non-GAAP financial measures exclude items, such as amortization expense, unusual litigation, impairment charges, restructuring charges, and acquisition and integration-related charges, that by their nature affect comparability of operational performance or that we believe obscure underlying business operational trends. The intangible asset amortization excluded from these non-GAAP financial measures represents the entire amount recorded within the Company's GAAP financial statements and is excluded because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised. The revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. The non-GAAP measures the Company provides are consistent with how management analyzes and assesses the operating performance of the Company, and disclosing them provides investor insight into management's view of the business. Management uses these adjusted financial measures for planning and forecasting in future periods, and evaluating segment and overall operating performance. In addition, management uses certain of the profit measures as factors in determining compensation.

Non-GAAP measures related to profit m

ITEM 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit Number Description

99.1 Press Release issued by Perrigo Company plc on November 4 , 2026 furnished solely pursuant to Item 2.02 of Form 8-K.

104 Cover Page Interactive Data file (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

(Registrant)

PERRIGO COMPANY PLC

By: /s/ Eduardo Bezerra

Dated: November 4, 2026 Eduardo Bezerra

Chief Financial Officer

Perrigo Reports Third Quarter 2026 Financial Results From Continuing Operations

• Execution of Three-S plan driving sequential improvement in operating results and market share gains across U.S. Store Brand OTC and key European brands³

• Infant Formula divestiture expected to simplify portfolio and sharpen focus on higher-return consumer self care categories⁴; strategic review of Oral Care business remains ongoing⁵

• Updated full-year 2026 outlook to reflect divestiture, more measured retailer inventory positioning, and continued softness in Europe

DUBLIN , November 4, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of consumer self-care products , today announced financial results from continuing operations for the third quarter ended September 26, 2026.

"Our Three-S plan is delivering continued progress in the areas of the business within our control," said Albert Manzone, Interim President and Chief Executive Officer. "We gained market share again in U.S. store brand OTC and in key European brands. Category trends improved sequentially, which, combined with disciplined cost management, helped offset a difficult consumer backdrop.

"The sale of Infant Formula is an important step in evolving Perrigo into a more focused consumer self-care company. It is expected t